000 | 01967 a2200553 4500 | ||
---|---|---|---|
005 | 20250513200053.0 | ||
264 | 0 | _c20000104 | |
008 | 200001s 0 0 fre d | ||
022 | _a0399-8320 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTaieb, S | |
245 | 0 | 0 |
_a[Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost]. _h[electronic resource] |
260 |
_bGastroenterologie clinique et biologique _cOct 1999 |
||
300 |
_a1048-54 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; English Abstract; Journal Article | ||
650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aBrachytherapy |
650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aData Interpretation, Statistical |
650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRadiotherapy Dosage |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVindesine _xadministration & dosage |
700 | 1 | _aVaillant, E | |
700 | 1 | _aPommier, P | |
700 | 1 | _aBonvoisin, S | |
700 | 1 | _aDesseigne, F | |
700 | 1 | _aMorignat, E | |
700 | 1 | _aGerard, J P | |
700 | 1 | _aMornex, F | |
773 | 0 |
_tGastroenterologie clinique et biologique _gvol. 23 _gno. 10 _gp. 1048-54 |
|
999 |
_c10549013 _d10549013 |